Radiometer is proud to announce that it is sponsoring the 1st World Sepsis Congress, from the 8th to the 9th of September 2016. Organized by the Global Sepsis Alliance, this free online event will give participants the chance to hear experts from around the world discuss the challenges and opportunities in the battle against this life-threatening illness.
Sepsis is the number one cause of preventable deaths worldwide, affecting over 20 million people every year. Radiometer is committed to raising awareness of the importance of early intervention, as well as providing the tools to help medical professionals identify and treat sepsis at the earliest possible opportunity. Last year, the company launched a rapid procalcitonin (PCT) assay – the biomarker of choice to aid the diagnosis of sepsis – which offers results in less than 21 minutes with the AQT90 FLEX immunoassay analyzer. Together with Radiometer’s portfolio of other relevant diagnostic and prognostic markers – including lactate, white blood cell count, CRP, creatinine, bilirubin and blood gases – this is helping to significantly improve turnaround times for sepsis diagnosis, improving the odds of patients making a full recovery.
Radiometer’s President, Henrik Schimmell, commented: “We are very pleased to be sponsoring the 1st World Sepsis Congress. This free online event fits well with our ongoing commitment to help improve global healthcare by providing reliable, fast and easy patient diagnoses. We encourage all healthcare professionals to sign up to this free event, which will highlight how early recognition and appropriate treatment can save lives.”
Register free for the 1st World Sepsis Congress at www.worldsepsiscongress.org
To find out more about Radiometer’s portfolio of acute care tests, please contact radiometer@radiometer.com or visit www.radiometer.com/en/diagnostics/sepsisdetection
